XSTO
QCORE
Market cap442kUSD
Jul 29, Last price
1.06SEK
1D
-7.83%
1Q
-40.78%
IPO
-97.89%
Name
Qlucore AB (publ)
Chart & Performance
Profile
Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Diagnostics, a software platform for multi-omics companion and precision diagnostics; and Qlucore Insights, a software for clinical data analysis. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2019‑04 | |
Income | ||||||
Revenues | 14,369 13.39% | 12,672 -10.24% | ||||
Cost of revenue | 6,971 | 10,309 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 7,398 | 2,363 | ||||
NOPBT Margin | 51.49% | 18.65% | ||||
Operating Taxes | 27 | 35 | ||||
Tax Rate | 0.36% | 1.48% | ||||
NOPAT | 7,371 | 2,328 | ||||
Net income | (15,681) -1.60% | (15,936) 36.64% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 67 | |||||
BB yield | -0.12% | |||||
Debt | ||||||
Debt current | (251) | 1,275 | ||||
Long-term debt | 2,000 | 3,183 | ||||
Deferred revenue | ||||||
Other long-term liabilities | (3,183) | |||||
Net debt | (26,870) | (65,274) | ||||
Cash flow | ||||||
Cash from operating activities | (16,949) | (8,049) | ||||
CAPEX | (192) | (19,015) | ||||
Cash from investing activities | (22,522) | (19,015) | ||||
Cash from financing activities | (1,275) | (808) | ||||
FCF | 7,496 | 2,398 | ||||
Balance | ||||||
Cash | 28,619 | 69,732 | ||||
Long term investments | ||||||
Excess cash | 27,901 | 69,098 | ||||
Stockholders' equity | 765 | (37,210) | ||||
Invested Capital | 81,528 | 136,401 | ||||
ROIC | 6.76% | 1.70% | ||||
ROCE | 8.99% | 2.38% | ||||
EV | ||||||
Common stock shares outstanding | 4,028 | 4,028 | ||||
Price | 7.85 -41.42% | 13.40 -52.65% | ||||
Market cap | 31,620 -41.42% | 53,976 -52.65% | ||||
EV | 4,750 | (11,297) | ||||
EBITDA | 11,434 | 6,103 | ||||
EV/EBITDA | 0.42 | |||||
Interest | 353 | 297 | ||||
Interest/NOPBT | 4.77% | 12.57% |